SCHEMBL11204758

SCHEMBL11204758

Cc1cc(C(=O)Nc2ccc3cc(S(=O)(=O)O)cc(O)c3c2)ccc1N

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP6 P55212 4/20 0.62
▸ CTDSP1 Q9GZU7 1/20 0.62
▸ NT5E P21589 2/20 0.62
▸ ENPP2 Q13822 4/20 0.56
▸ NSD2 O96028 4/20 0.50
▸ PRMT1 Q99873 3/20 0.50
▸ DUSP3 P51452 2/20 0.50
▸ PTPN5 P54829 2/20 0.50
▸ PTPN11 Q06124 2/20 0.50
▸ CASP7 P55210 1/20 0.50
▸ MAOA P21397 1/20 0.46
▸ MAOB P27338 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ APEX1 P27695 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11440915 0.92 CASP6 (0.73) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL11435460 0.91 CASP6 (0.54) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL11208054 0.91 CASP6 (0.62) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL10905493 0.87 NT5E (0.59) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL11339168 0.86 NT5E (0.58) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL11433774 0.86 CASP6 (0.64) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL7897823 0.85 CASP6 (0.65) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL6017879 0.85 CASP6 (0.84) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL11435442 0.83 CASP6 (0.49) CASP6CTDSP1NT5EENPP2NSD2
SCHEMBL11426163 0.83 CASP6 (0.73) CASP6CTDSP1NT5EENPP2NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0013784-B1 C-SUBSTITUTED NAPHTHALENEMONOSULFONIC UREIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AMERICAN CYANAMID COMPANY (US) 1983-02-23 — — EP disclosed
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 — — US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 — — EP disclosed
US-4216165-A Amine precursors to ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
US-4216166-A Nitro precursors to amine precursors to ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
Send feedback